• GlaxoSmithKline profits slip in third quarter | Breaking News
  Pharmaceutical giant GlaxoSmithKline said Wednesday that third-quarter profits fell owing to fierce competition from generic drugs and sliding sales of controversial diabetes drug Avandia. Net profits sank 5.8 percent to 1.310 billion pounds in the th...
  in Public bookmarks with glaxosmithkline profits quarter slip third

glaxosmithkline from all users